Navigation Links
SCOLR Pharma, Inc. Announces Engagement of HealthPro as Financial Advisor
Date:4/2/2009

historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation statements related to our on-going evaluation of prospective transactions and the involvement of HealthPro in this process. These forward-looking statements involve risks and uncertainties, including activities, events or developments that we expect, believe or anticipate will or may occur in the future. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including our ability to successfully develop new formulations and complete research and development, including pre-clinical and clinical studies, our ability to raise additional funds, the continuation of arrangements with our product development partners and customers, competition, government regulation and approvals, and general economic conditions. For example, if our clinical trials are not successful or take longer to complete than we expect, we may not be able to develop and commercialize our products and we may not obtain regulatory approval for our products, which would materially impair our ability to generate revenue. Additional assumptions, risks and uncertainties are described in detail in our registration statements, reports and other filings with the Securities and Exchange Commission. Such filings are available on our website or at www.sec.gov. You are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances.

    Contact:
    Investor Relations:
    Cameron Associates
    Kevin McGrath
    212.245.4577
    Kevin@cameronassoc.com


'/>"/>
SOURCE SCOLR Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation
2. SCOLR Pharma, Inc. Schedules Third Quarter 2008 Financial Results Conference Call for November 7, 2008 at 11:30 A.M. Eastern
3. SCOLR Pharma, Inc. Announces Positive Top-Line Results From Pivotal Clinical Trial Evaluating Efficacy of Extended-Release Ibuprofen
4. SCOLR Pharma, Inc. Announces Resignation of CEO Daniel O. Wilds
5. SCOLR Pharma, Inc. Announces Appointment of Bruce S. Morra, Ph.D., as President & CEO
6. SCOLR Pharma, Inc. Schedules Fourth Quarter 2008 Financial Results Conference Call for March 11, 2009 at 11:30 A.M. Eastern
7. GeoPharma, Inc. to Present at the EdgeWater Research Investor Conference
8. TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD
9. Legislative and Regulatory Outlook - 2009 and Beyond for Pharma, Biotech Players
10. Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
11. Why Do Drugs Cost So Much? and why are we so darn sick?: New Book Reveals Inner Workings of Big Pharma, Asks Hard Questions About Our Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Stem cells that could one day provide therapeutic ... harvested from the tissue of the umbilical cord, just ... cells to treat some blood disorders, said University of ... version of the Journal of Biomedicine and ... be expanded to greater number, are remarkably stable and ...
(Date:12/17/2009)... Vomiting syndrome made him a recluse at times, ... -- An Australian researcher claims he has identified ... Darwin to suffer nausea, vomiting, headaches and skin ... Numerous mental and physical diagnoses have been suggested ... that Darwin would become a virtual recluse for ...
(Date:12/17/2009)... the aging inequity , , THURSDAY, Dec. 17 ... gender inequity: Women develop more and deeper wrinkles ... do. , The disadvantage had long been suspected, ... said Dr. Foad Nahai, a plastic surgeon practicing ... Surgery Journal . The study appears in the ...
(Date:12/17/2009)... of nimotuzumab , ... (PRWEB) ... Therapure Biopharma Inc. and David Allan, Chairman and CEO of ... under which Therapure Biopharma will provide aseptic fill and finish ... majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of ...
(Date:12/17/2009)... -- Over the last few weeks there has been ... is used by e cigarette opposition in an attempt ... are questioning the tactics of these groups when the ... safer alternative to tobacco according to several studies, lab ... specialist around the world. ,, Special interest groups ...
Breaking Medicine News(10 mins):Health News:Umbilical cord could be new source of plentiful stem cells, say Pitt researchers 2Health News:New Theory Emerges on Darwin's Illness 2Health News:Mouth Area Wrinkles More in Women Than Men 2Health News:Mouth Area Wrinkles More in Women Than Men 3Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 2Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 3Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 4Health News:Special Interest Deceptions Continue to Rampant About Electronic Cigarettes 2
... The best-established biomarkers for Alzheimers disease have a low ... the inclusion of these biomarkers in clinical trials of ... are presented by researchers at the Sahlgrenska Academy at ... the Journal of Alzheimers Disease. , We show ...
... stress symptoms 2.3 times more likely to have respiratory condition ... male twins who served in Vietnam has uncovered a strong ... University researchers, reporting in the Nov. 15 issue of the ... found that those who suffered the most from PTSD were ...
... to Bring Together Presidential ... Crisis, LAKE FOREST, Calif., Nov. 15 Sen. Hillary Clinton,(D-N.Y.) ... the third annual Global Summit on AIDS and the Church to,be ... Forest, Calif.,and hosted by pastor and "The Purpose Driven Life" author ...
... & more for those with disabilities at Rehabilitystores.com, ... store at http://www.rehabilitystores.com offers thousands of,unique ... the aging and,their families. More than a store ... the lifestyle of those who,also happen to be ...
... You,ll never have to get into a,cold bed ... try not to,get too heated up by all of ... and individual,customization, there are more options to choose from ... retailer Comfort House,( http://www.comforthouse.com ). Gornstein evaluates dozens of ...
... Nov. 15 Therap Services announces the,release of ... and reporting applications. Therap version 7.1 will feature ... and Safeguards,and new enhancements to existing Therap modules ... module. The Individualized Plan of Protective Oversight ...
Other Medicine News:Health News:Biomarkers for Alzheimer's disease can be trusted in clinical trials 2Health News:Vietnam Vets Study Links Asthma and PTSD 2Health News:Sen. Clinton First to Confirm Participation at Global Summit on AIDS and the Church: 2Health News:Sen. Clinton First to Confirm Participation at Global Summit on AIDS and the Church: 3Health News:Online Shopping For Those with Disabilities and the Aging 2Health News:What's New in Electric Blankets and Heated Mattress Pads 2Health News:Therap Services Announces Release 7.1 for the Developmental Disability Community 2Health News:Therap Services Announces Release 7.1 for the Developmental Disability Community 3
(Date:12/16/2009)... -- HDT Engineered Technologies (HDT), a leader in ... principal subcontractor for the mechanical development of the ... anthropromorphic arm technology that will give patients improved, ... including a sense of touch. ,, As ... (DARPA) Revolutionizing Prosthetics 2009 (RP2009) project, the MPL ...
(Date:12/16/2009)... International, Inc. (OTCQX: DATA), a technology and ... for the clinical trials industry, today announced ... Software. This release advances the Company,s ... and introduces two new mechanisms for facilitating ... Center(TM) and the DATATRAK Learning Manager(TM). ...
(Date:12/16/2009)... Iceland, December 16 Scientists at,deCODE genetics, ... Nature the,discovery of a version of a common ... (SNP) with a major impact on susceptibility to ... variant is not only large, but unusual:,if an ... increases risk of,T2D by more than 30% compared ...
Breaking Medicine Technology:HDT Develops Robotic Arm Technology for DARPA's Revolutionizing Prosthetics 2009 Program 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 1Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 2Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 3Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 4New biomarker predicts response to hepatitis C treatment 54593 1New biomarker predicts response to hepatitis C treatment 54593 2New biomarker predicts response to hepatitis C treatment 54593 3New biomarker predicts response to hepatitis C treatment 54593 4Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia 9587 1Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia 9587 2Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia 9587 3
... Finds Statins Cut Risk of Heart Attacks, Deaths, ... cause of death among Americans, costing our healthcare,system hundreds ... is new hope for preventing this fatal disease - ... A new study has found that millions of ...
... Venter Shares Award with James D. Watson, Marilyn & James ... ROCKVILLE, Md., Nov. 12 J. Craig Venter,Ph.D., Founder and ... Double Helix Medal from Cold Spring Harbor Laboratory (CSHL) on,November ... Dr. Venter received the Double Helix Medal along with Dr. ...
Other Medicine Technology:Seniors Can Be Heartened by New Study on Statins 2J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2
... a rigid gas lens with high oxygen ... as hard contact lens, it can provide ... against astigmatism. The key feature of Menicon ... fluoromethacrylate, Siloxanylmethacrylate and methacrylic acid, which realizes ...
Magniclear is the first presbyopic lens to combine the clear distance optics of a spherical lens, the intermediate visual performance of a multifocal and the predictably crisp, near power of a bifoca...
Boston Multivision design is manufactured in Boston ES material for early presbyope patients. Boston Multivision lens provides crisp, clear vision at near, intermediate, and far distances and excelle...
... to stain intraocular membranes in vitreoretinal surgery, ... injecting Membraneblue in an air-filled vitreous cavity, ... the dye. After removal of all excess ... can easily be distinguished from the underlying, ...
Medicine Products: